Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs

Journal of the National Cancer Institute

Volumn 90, Issue 4, 1998, Pages 307-315

  Okamoto, Isamu ^a   Morisaki, Tetsuro ^a   Sasaki, Ji Ichiro ^a   Miyake, Hideaki ^a,b   Matsumoto, Mitsuhiro ^a   Suga, Moritaka ^a   Ando, Masayuki ^a   Saya, Hideyuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; HERMES ANTIGEN; RNA;

ARTICLE; CANCER CELL; CELL MIGRATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; OPEN READING FRAME; PLEURA EFFUSION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TARGET CELL; TUMOR SUPPRESSOR GENE; URINARY TRACT DISEASE;

EID: 0032542497     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.4.307     Document Type: Article

References (57)

1. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
2. Urban T, Ricci S, Grange JD, Lacave R, Boudghene F, Breittmayer F, et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 1993;85:2008-12.
3. Fitzgerald JM, Ramchurren N, Rieger K, Levesque P, Silverman M, Libertino JA, et al. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J Natl Cancer Inst 1995;87:129-33.
4. Johnson PW, Burchill SA, Selby PJ. The molecular detection of circulating tumour cells. Br J Cancer 1995;72:268-76.
5. Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis [published erratum appears in J Natl Cancer Inst 1995;87:1643]. J Natl Cancer Inst 1995;87:1056-60.
6. Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995;345:1257-9.
7. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 1996;271:659-62.
8. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
9. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035-7.
10. Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, et al. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer 1997;70: 52-6.
11. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997;89:724-30.
12. Siebert PD, Larrick JW. Competitive PCR. Nature 1992;359:557-8.
13. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989;56:1057-62.
14. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
15. Seth A, Gote L, Nagarkatti M, Nagarkatti PS. T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci U S A 1991;88: 7877-81.
16. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992;257:682-5.
17. Thomas L, Byers HR, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 1992;118:971-7.
18. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992;267:4732-9.
19. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992;89:12160-4.
20. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells [letter], EMBO J 1991;10:343-8.
21. Jackson DG, Screaton GR, Bell MV, Bell JI. CD44 and cancer. Lancet 1993;341:252-3.
22. Fox SB, Gatter KC, Jackson DG, Screaton GR, Bell MV, Bell JI, et al. CD44 and cancer screening [letter]. Lancet 1993;342:548-9.
23. Gotley DC, Fawcett J, Walsh MD, Reeder JA, Simmons DL, Antalis TM. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 1996;74:342-51.
24. Günthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
25. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-7.
26. Tanabe KK, Nishi T, Saya H. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol Carcinog 1993;7: 212-20.
27. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, et al. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993;342:1019-22.
28. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
29. Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;344:1470-2.
30. Koretz K, Moller P, Lehnert T, Hinz U, Otto HF, Herfarth C. Effect of CD44v6 on survival in colorectal carcinoma [letter]. Lancet 1995;345: 327-8.
31. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995;345:615-9.
32. Friedrichs K, Kugler G, Franke F, Terpe HJ, Arlt J, Regidor PA, et al. CD44 isoforms in prognosis of breast cancer [letter]. Lancet 1995;345: 1237.
33. Günthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K. Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 1995;24:19-42.
34. Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrancois D. Theillet C. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Int J Cancer 1995;64:347-54.
35. Herrlich P, Pals S, Ponta H. CD44 in colon cancer. Eur J Cancer 1995; 31A:1110-2.
36. Finke LH, Terpe HJ, Zorb C, Haensch W, Schlag PM. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins [letter]. Lancet 1995;345:583.
37. Finke LH, Zorb C, Haensch W, Schlag PM, Terpe HJ. Expression of CD44 isoforms - a new histopathologic parameter in colorectal carcinoma? Zentralbl Chir 1996;121:450-4.
38. Woodman AC, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, et al. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol 1996;149:1519-30.
39. Seelentag WK, Gunthert U, Saremaslani P, Futo E, Pfaltz M, Heitz PU, et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 1996;69: 218-24.
40. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, et al. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 1996;14:1122-7.
41. Miwa T, Watanabe A, Yamada Y, Shino Y, Yamada T, Yamashita J, et al. Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer 1996; 77:25-9.
42. Wong LS, Cantrill JE, Morris AG, Fraser IA. Expression of CD44 splice variants in colorectal cancer. Br J Surg 1997;84:363-7.
43. Soukka T, Salmi M, Joensuu H, Hakkinen L, Sointu P. Koulu L, et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 1997;57:2281-9.
44. Tanabe KK, Ellis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993;341:725-6.
45. Takano T, Sumizaki H, Nakano K, Matsuzuka F, Kuma K, Amino N. Increased expression of CD44 variants in differentiated thyroid cancers. Jpn J Cancer Res 1996;87:1245-50.
46. Takahashi K, Stamenkovic I, Cutler M, Saya H, Tanabe KK. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 1995;11:2223-32.
47. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-8.
48. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 1994;308:619-24.
49. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995;177:11-20.
50. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res 1995;55:4273-7.
51. Yoshida K, Sugino T, Bolodeoku J, Warren BF, Goodison S, Woodman A, et al. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene. J Clin Pathol 1996;49:300-5.
52. Light RW. Pleural effusions. Med Clin North Am 1977;61:1339-52.
53. Sahn SA. Pleural effusion in lung cancer. Clin Chest Med 1993;14: 189-200.
54. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991;114:271-6.
55. Sarnacki CT, McCormack LJ, Kiser WS, Hazard JB, McLaughlin TC, Belovich DM. Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1,400 patients. J Urol 1971;106: 761-4.
56. Farrow GM, Utz DC, Rife CC. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res 1976;36:2495-501.
57. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-65.